Amneal Takes Control Of Kashiv Specialty In $100m+ Deal
Points To Value Of 505(b)(2) Pipeline And Complex Generics Experience
Amneal will take a majority stake in Kashiv Specialty Pharmaceuticals after striking a deal worth potentially more than $100m for a 98% stake in the hybrid 505(b)(2) and complex generics specialist.
